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Abstract
The phenotypic effect of some single nucleotide polymorphisms (SNPs) depends on their parental origin. We present a
novel approach to detect parent-of-origin effects (POEs) in genome-wide genotype data of unrelated individuals. The
method exploits increased phenotypic variance in the heterozygous genotype group relative to the homozygous groups.
We applied the method to .56,000 unrelated individuals to search for POEs influencing body mass index (BMI). Six lead
SNPs were carried forward for replication in five family-based studies (of ,4,000 trios). Two SNPs replicated: the paternal
rs2471083-C allele (located near the imprinted KCNK9 gene) and the paternal rs3091869-T allele (located near the SLC2A10
gene) increased BMI equally (beta = 0.11 (SD), P,0.0027) compared to the respective maternal alleles. Real-time PCR
experiments of lymphoblastoid cell lines from the CEPH families showed that expression of both genes was dependent on
parental origin of the SNPs alleles (P,0.01). Our scheme opens new opportunities to exploit GWAS data of unrelated
individuals to identify POEs and demonstrates that they play an important role in adult obesity.
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Forsythe test, modified to test the mean absolute deviations from the
median in the heterozygous and homozygous groups (see Materials
and Methods for details). We applied this test to BMI values
(corrected for age and age-squared), separately in men and women, in
15 studies, totalling up to 56,092 individuals (detailed description of
the cohorts can be found in Tables S1–S3), 13 of which participated
in previous meta-analyses of the GIANT consortium [10]. In total
2,673,768 HapMap imputed and genotyped SNPs were tested. For
each locus, a lead SNP (with the strongest POE association) was
identified; other markers within 1 Mb or in LD (r2.0.1) were
excluded from further investigations. Sex-specific association summary statistics were then meta-analysed. No sex specific difference in
effects were observed, therefore all reported results are sex-combined.
Our criteria to select SNPs to take forward to the replication stage
resulted in the selection of six independent SNPs: four lead SNPs
with POE P-value ,561026 and three SNPs in imprinted regions
with P,561024 (see Fig S1 for QQ-plot), one SNP fulfilled both
criteria. See Table 1 for details of these results and Materials and
Methods for details of the applied selection methods. These six
SNPs were carried forward to the replication stage.

Introduction
The effect of genetic variants on phenotypes may depend upon
the parent from whom the variant was inherited [1,2]. Parent-oforigin effects (POEs) may arise through imprinting; mechanisms of
which include cytosine methylation and histone deacetylation [2].
To date around 50 human genes are known to be imprinted and
for most mammalian species less than 1% of the genome is
confirmed to be imprinted [3]. One plausible explanation for this
phenomenon is the parental conflict hypothesis, whereby both
parents would like to maximize the influence of their genome on
their offspring [4]. Current methods for detecting parent-of-origin
effects rely on assigning parental ancestry to the inherited alleles.
This is straightforward in linkage studies, which have identified
potential POEs on type 2 diabetes, body mass index (BMI) [5,6],
and alcohol intake [7–9]. However, only a very few of these findings
have been replicated and the identified linkage peaks often span
large chromosomal regions harbouring hundreds of genes, hence
the causal gene or regulatory sequence is unknown. A notable
exception is the work of Kong et al [1] who inferred parental origin
through genealogy information and long-range phasing to subsequently test for POEs. This study identified six SNPs, four
associated with risk of type 2 diabetes and the other two associated
with each of breast cancer and basal-cell carcinoma.
Genome-wide association studies (GWASs) of unrelated individuals have very precisely identified a large number of genetic loci
harbouring SNPs whose (alternative) allele counts associate with
common traits. Since GWASs predominantly include unrelated
individuals, the parental origin of the alleles cannot be determined,
hence genetic effects influenced by the parental origin of the alleles
are typically not considered. Here we present a novel approach
that is able to detect POEs using genome-wide genotype data of
unrelated individuals. We chose BMI as our target trait, due to
previous findings [5,6] and the large available sample size. We
report the discovery of two novel loci affecting BMI in a manner
dependent on the parent-of-origin of the transmitted alleles.

Replication in family-based studies
The replication stage utilised five family-based studies (see Tables
S1–S3) to test for parent-of-origin effects at the six selected SNPs.
Only heterozygous individuals are informative when testing for
parent-of-origin effects; the number of heterozygous individuals for
each of the tested SNPs ranged from 1,122 to 4,128 (see Table 2 and
Table S4). A simplified parental asymmetry test (PAT, see Materials
and Methods) was applied and SNPs successfully replicated if their
PAT P-values were below 0.0083 (Bonferroni corrected significance
threshold for family-wise error of 0.05 with six tests). Two of these
SNPs, rs2471083 [T/C] (GWAS discovery BMI variance (het vs.
hom): 1.058 vs 0.963, PPOE = 9.3461027; replication PAT
P = 0.00264) and rs3091869 [T/C] (GWAS discovery BMI variance
(het vs. hom): 1.046 vs 0.957, PPOE = 4.761026; replication PAT
P = 0.00245) successfully replicated. In particular, we found that
heterozygous individuals who carry the rs2471083-C allele paternally have 0.11 (SD unit) higher BMI on average than those carrying
the C-allele maternally (P = 0.00264). Heterozygous carriers of the
paternal rs3091869-C allele have 0.11 (SD unit) lower BMI on
average than those carrying the maternal C-allele (P = 0.00245).
Figure 2 shows the locuszoom plots of the POE association P-values
for the two replicated loci (KCNK9 and SLC2A10).

Results
We applied our POE test, which compares the phenotypic
variance of the heterozygous genotype group to the variance
observed in the homozygous groups, to all SNPs genome-wide.
The test, which is applicable to unrelated individuals, assumes that an
increased variance in the heterozygous group arises because the
heterozygous group consists of two subgroups (paternal reference
allele/maternal alternative allele and maternal reference allele/
paternal alternative allele) each with different means (see Figure 1).
Differences in phenotypic variance were tested using the BrownPLOS Genetics | www.plosgenetics.org
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cell lines (LCL) of the CEPH families. These cell lines have been
used extensively to identify imprinted genes [18,19]. Using the
available trio data we could infer the parental origin of the alleles
of rs2471083 and rs3092611 in 33 (9 maternal T alleles, 24
paternal T alleles) and 24 (16 maternal T alleles, 8 paternal T
alleles) individuals respectively (Table S7). We performed between
2 and 10 technical replicates per individual (mean of 7.75) and
samples with high coefficient of variation (.5%) were discarded in
order to ensure robustness. After quality control, 124 expression
values from 23 (mat:pat = 4:19) samples for KCNK9 and 240
expression values from 24 (mat:pat = 16:8) for SLC2A10 were
available for analysis. We fitted a linear mixed model to test for
association between expression levels (Ct values) and allelic origin.
The paternal T allele of rs2471083 was associated with lower
KCNK9 expression levels (+1.08 [SD unit] Ct values, P = 0.0096),
and the paternal T allele of rs3092611 was associated with higher
SLC2A10 expression values (21.09 [SD unit] Ct values,
P = 0.0023). To ensure there was no systematic bias in our
experiments giving rise to spurious POE associations we repeated
the qPCR experiments for two housekeeping genes GAPDH and
HRPT1. Both analyses gave non-significant POE P-values (P.
0.3).

Author Summary
Large genetic association studies have revealed many
genetic factors influencing common traits, such as body
mass index (BMI). These studies assume that the effect of
genetic variants is the same regardless of whether they are
inherited from the mother or the father. In our study, we
have developed a new approach that allows us to
investigate variants whose impact depends on their
parental origin (parent-of-origin effects), in unrelated
samples when the parental origin cannot be inferred. This
is feasible because at genetic markers at which such
effects occur there is increased variability of the trait
among individuals who inherited different genetic codes
from their mother and their father compared to individuals
who inherited the same genetic code from both parents.
We applied this methodology to discover genetic markers
with parent-of-origin effects (POEs) on BMI. This resulted in
six candidate markers showing strong POE association. We
then attempted to replicate the POE effects of these
markers in family studies (where one can infer the parental
origin of the inherited variants). Two of our candidates
showed significant association in the family studies, the
paternal and maternal effects of these markers were in the
opposite direction.

Methylation lookups
POEs can be driven by differences between inherited paternal
and maternal methylation. To explore whether the observed
parent-of-origin effects at our discovered SNPs were driven by
differential methylation we tested whether methylation in the
regions (Chr8: 140.45–140.65 Mb and Chr20: 45.3–45.55 Mb)
was (i) associated with the two respective SNPs (rs2471083,
rs3091869) in 262 unrelated individuals from the TwinsUK cohort
and (ii) associated with BMI in two independent cohorts: 79 BMI
discordant (difference .0.5 SD) monozygotic twin pairs from the
TwinsUK cohort and a sample of 412 unrelated individuals from
the EPIC-Italy cohort. None of these analyses showed significant
association (see Supplemental Data S1, Figures S2, S3 and Table
S8 for further details).

((bM zbP )=2) from the largest-to-date meta-analytic study on
BMI [10], we estimated the effects of the maternal and paternal
alleles. For both rs2471083-C and rs3091869-T we obtained
bM ~{0:055 and bP ~0:055. Using these effect sizes and the
population frequency of these SNPs, we calculated the explained
variance of these SNPs (if their parent of origin is known) to be
0.24% and 0.30% for rs2471083 and rs3091869, respectively.
These effects are comparable to that of the strongest BMIassociated variant in the FTO gene (0.34%) [10].
Notably, rs2471083 is located 105 kb upstream of the imprinted
gene KCNK9. Mutations in this potassium channel gene cause
Birk-Barel syndrome, a maternally transmitted syndrome of
mental retardation, hypotonia, and unique dysmorphism, resulting
from genomic-imprinting [11]. SNPs within 2 kb have been shown
to be associated with HDL cholesterol, adiponectin levels [12] and
blood pressure [13]. Its impact on hypertension is potentially via a
mechanism involving aldosterone, the concentration of which
correlates strongly with fat mass. Interestingly, KCNK9 knock-out
mice exhibited more fragmented sleep episodes [14] and 7.1%–
9.6% increased weight gain (P = 0.02) at 19–20 weeks of age [15].
SNP rs3091869 is 61 kb upstream of SLC2A10, a glucose
transporter involved in arterial morphogenesis. SNPs in low LD
(in CEU r2 = 0.05) with rs3091869 have been shown to alter body
fat distribution [16].
We tested these two confirmed SNPs in 705 trios with paediatric
(extreme) obese offspring in which parental origin of the alleles was
known in up to 255 individuals [17]. No significant effect was
observed (see Table S5). This could be due to insufficient power,
different genetic mechanisms between young individuals and
adults or that our association is specific to variations within the
range of normal BMI.

Discussion
Our novel approach revealed two SNPs, located near the genes
KCNK9 and SLC2A10, influencing BMI in a parent-of-origin
specific fashion. These loci were the first and fourth most
significant genome-wide in our new POE test for unrelated
individuals and both showed significant parent-of-origin effects in
family studies. Both SNPs exhibit polar overdominance, where
homozygous individuals have equal (baseline) phenotypes and
heterozygous genotypes confer relative risk/protection, depending
on the parental origin. Polar overdominance, has been observed in
humans for type2 diabetes [1] and BMI [20], however it is very
rare and its molecular mechanism is unknown.
RT-PCR experiments revealed that gene expression levels of
KCNK9 and SLC2A10 in LCLs were also influenced in a parentof-origin manner. The expression of these genes is highest in the
brain (although it is also expressed in testis, liver, colon, adrenal
gland and kidney; see http://www.genecards.org/) indicating a
potential neuronal involvement. Expression levels of KCNK9 and
SLC2A10 in living brain cells might have been more informative
and robust, however, such information is not available. The
applied qPCR method was optimised to ensure that the expression
levels measured in LCLs were representative only of the target
transcript and amplification efficiency was assessed to be sensitive
enough to allow the detection of even small changes in gene
expression. Interestingly, rs2471083 alleles, regardless of their

Expression experiments
We evaluated whether the parent of origin effect of the
rs2471083-T and rs3092611-T (proxy for rs3091869-T,
r2 = 0.998) alleles can be observed in the expression levels of their
respective genes (KCNK9 or SLC2A10). To test this we carried
out quantitative PCR (qPCR) experiments using lymphoblastoid
PLOS Genetics | www.plosgenetics.org
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Figure 1. Explanation of the POE test. Top panel illustrates the phenotype distributions in the four genotype groups that would be observed if
the parent-of-origin of the alleles were known. Bottom panel shows how these distributions change if the parent-of-origin is unobserved. The
resulting heterozygous group will have increased variance due to its heterogeneity. This example describes a scenario we observe for the two
replicated hits, namely that the paternal- and maternal effects are of the same size, but opposite in direction (bM ~{bP ). Therefore the average
phenotype in the B/B group is the same as in the A/A group, as the paternal and maternal B allele effects cancel each other out. In the A/B group
there are two subpopulations: the A-pat/B-mat group with phenotypic mean of bM and the A-mat/B-pat group with bP mean. Thus, the two
subpopulations combined also have zero mean, but increased variance.
doi:10.1371/journal.pgen.1004508.g001

A previous study proposed to detect POE in inbred F2 mice by a
two-component mixture distribution fitting of the heterozygous
genotype group and further two components for the homozygous
groups [22]. This method requires a parametric distribution of the
phenotype to be assumed, small violations of this assumption can
result in heavily biased parameter estimates. The method we chose
is more robust to a wide range of phenotype distributions (due to
the underlying Brown-Forsythe test employed), computationally
faster (making it attractive for testing millions of SNPs) and
applicable to probabilistic genotype calls. Our POE test for
unrelated GWAS samples is similar to a test proposed to detect
gene-environment interactions [23] in that it exploits differences in
phenotypic variance to detect a phenomenon not directly
measured. Inflated phenotypic variance in the heterozygous group
might also be the result of other phenomenon: (i) a phenotype
altering effect (be it genetic or environmental) acting only on the

parental origin, show marginally significant association (P = 0.03)
with KCNK9 expression levels in the hippocampus (http://www.
broadinstitute.org/gtex/). Our methylation analyses did not reveal
any evidence that the POEs were driven by differences in inherited
paternal and maternal methylation. Neither of our two SNPs tag
common copy number variants (CNVs) (based on the CNV
reference data used in Heid et al. [21]) and we found only one
sample (out of 14,315 available in-house, whose BMI Z-score was
+1.18) with a 76 kb deletion overlapping rs2471083. Hence, the
effect of the two discovered SNPs are unlikely to be driven by
CNVs. To check whether the two confirmed SNPs (rs3091869,
rs2471083), or SNPs in LD (10 with r2.0.8 in 1000 Genomes
EUR population), show regulatory activity, we queried RegulomeDB (http://regulome.stanford.edu). None of these SNPs were
annotated to have more than minimal binding evidence
(RegulomeDB score below 4).
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For each target SNP, in each family we searched for trios (or parent-offspring pairs) with heterozygous offspring and determined the parent of origin of the alleles (whenever possible). From each family at most one heterozygous
offspring with known parental origin was then collected and grouped according to the parental origin of the alleles. The equality of phenotypic means in the two groups was tested using a Student t-test (‘‘P-value for beta
difference column’’). The difference between the phenotypic means were meta-analysed using inverse-variance weighting. Table notations: ‘‘beta meta’’ and ‘‘P meta’’: meta-analysis estimate of beta (coded paternal) - beta (coded
maternal) effect size differences and the corresponding P-value, ‘‘N meta’’: total number of heterozygous offspring with (coded-maternal/other-paternal), (coded-paternal/other-maternal) genotypes, respectively.
doi:10.1371/journal.pgen.1004508.t002
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Table 2. Replication of the 6 discovery SNPs in trios (or parent-offspring pairs).

SNP matching any of the following two selection criteria were retained: (1) All lead SNPs with POE P-value below 561026. (2) All lead SNPs falling in previously reported imprinted regions with POE P-value ,561024. Note that one
SNP is listed twice as it met both criteria. Chr: chromosome, Gene: nearest gene, MAF: minor allele frequency, N (AA+BB): homozygous sample size, N (AB): heterozygous sample size, P-value (main): main effect association P-value
in Speliotes et al. [10]. The parent of origin P-value, ‘‘P-value (POE)’’, is the Brown-Forsythe test P-value. SNPs marked in bold are those which replicated in the family studies, see Table 2.
doi:10.1371/journal.pgen.1004508.t001
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Figure 2. Local association plots. Panels show the local POE association P-values for the KCNK9 (left panel) and SLC2A10 (right panel) loci.
doi:10.1371/journal.pgen.1004508.g002

further reducing the likelihood of an artefact resulting from the
scale on which the phenotype is measured [24].
Some of the negative results of the other SNPs carried forward
to the replication phase in the family data could be explained by
lack of power. The power to replicate POE associations in familybased studies is dependent on the available number of heterozygous individuals (for details see Supplemental Data S1) and thus
increases with minor allele frequency (MAF). Therefore, it is
unsurprising that the two SNPs which replicated had relatively
high MAF (.27%).
Linkage studies have identified four regions exerting POE on
BMI (10p12, 12q24, 13q32) [5] and 2q31 [27]). We looked up
SNPs in these regions in our genome-wide discovery POE
association results. The reported linkage regions showed enrichment for lower than expected POE P-values (see Figure S4 for
regional QQ-plots), however, no SNPs survived Bonferroni
correction. We also tried to replicate a SNP in exon 5 of DLK1
(rs1802710) because this SNP showed polar overdominance for
obesity in children [20], but only a very slight trend (P = 0.32) was
visible in our study. Previously reported BMI-associated loci [10]
show some enrichment for lower POE P-values (Supplemental
Data S1, Tables S9, S10 and Figure S5), however these need to be
replicated in family studies.
Previous work comparing strength of associations of motheroffspring BMI with father-offspring BMI did not reveal intrauterine influence on obesity in children [28]. A similar conclusion was
reached in a systematic review of seven studies [29], while stronger
maternal influence was observed in a recent longitudinal study
[30]. The difference in conclusions may be due to that fact that the
former studies included predominantly older children than the
longitudinal study (0–3.5 years). At early age the diet of the
offspring may be more similar to that of the mother than the father
(e.g. due to breastfeeding), which might have contributed to the
higher mother-offspring BMI similarity found by Linabery et al.
[30].
In summary, our findings indicate that POEs may play a role in
adult obesity. The two identified SNPs have strong parent-oforigin effect on BMI, close to that of the FTO, contributing
substantially to the heritability of BMI. Our follow-up experiments
demonstrated parent-of-origin specific gene expression modulation, but failed to link methylation activity of these loci to BMI
values. Inevitably for newly discovered loci, further studies are
warranted to determine how these variations functionally influence
obesity in humans. The reliance of our approach on difference in
phenotypic variance means that it cannot be extended to binary

heterozygous group; (ii) an overdominant effect combined with a
genetic or environmental interaction or non-linear, monotonic
phenotype transformation that has different derivatives for low
and high trait values; (iii) a large marginal additive effect combined
with a (monotonic) transformation for which the second derivative
is maximised at the mean phenotype value of the heterozygous
group (see Materials and Methods for details). More generally, the
combination of the scale on which the phenotype is measured and
a strong marginal association with an allelic dosage may give rise
to spurious associations using variance tests [24]. Recently some
evidence has emerged about loci which effect the variance of
phenotypes (through impacting environmental plasticity, canalization, developmental stability, etc.) that can be detected via
association with phenotypic variability [25]. Therefore, the top hits
obtained by our POE test may need further prioritisation before
proceeding to trio-based confirmation. We recommend the
following checks: (a) Exclude SNPs with overdominant effects;
(b) For SNPs with low POE P-value, test gene-environment (GxE)
interaction (as done in [23]) via modelling phenotypic variance as
a function of the genotype dosage (coded in additive, recessive or
dominant fashion). If this test is more significant than the POE
test, it is probably a GxE that is driving the POE association and
also as a side effect we will observe significant difference in the
variance between the two homozygous groups. (c) If a SNP with
low POE P-value has marginal effect on the trait, repeat the POE
test for various transformed versions of the phenotype such as log
and inverse-normal quantile. If the resulting POE P-values are not
robust, give lower priority to the examined SNP.
For our confirmed SNPs multiple lines of evidence show that
the parent-of-origin effects are real, most convincingly clear
replication in independent family data of parent-of-origin associations of the hit SNPs with both BMI and gene expression levels.
Further, the GWAS discovery associations are very unlikely to be
artefacts of the factors discussed above: (i) there is no evidence of
overdominant, additive, recessive or dominant effects (the mean
BMI values are near identical in the three genotype groups), hence
the signals cannot be driven by gene-environment interactions or
be an artefact of the scale on which the phenotype is measured (ii)
no SNP within 500 kb has any detectable marginal effect on BMI
thus the association cannot be driven by haplotype-specific
marginal effects [26]; (iii) the phenotypic variances in the two
homozygous groups, are almost identical (rs2471083: s2CC ~0:96,
s2CT ~1:06, s2TT ~0:98 and rs3091869: s2CC ~0:97, s2CT ~1:05,
s2TT ~0:95); (iv) POE test with log- and inverse-normal quantile
transformed BMI values resulted in similar results (Table S6),
PLOS Genetics | www.plosgenetics.org

7

July 2014 | Volume 10 | Issue 7 | e1004508

SNPs in SLC2A10 and KCNK9 Exhibit Parent-of-Origin Effect on BMI

In the presence of a marginal association a phenotype
transformation could alter the genotype group variances and
introduce bias into the test [24]. For this reason we analysed
untransformed age-, age2-corrected BMI values (normalised to
have zero mean and unit variance) separately for men and women.
Standard variance tests (such as the F-test) are, however, sensitive
to deviations from the Gaussian distribution.
Therefore, we used a robust version of the Brown-Forsythe test.
Briefly, we first centred the phenotype values (at zero) in each
genotype group to avoid inflated variance in the presence of
marginal effects in the group of all homozygote individuals. We
denote these centred phenotypes by z, where

outcomes. Since there are other phenomena which can give rise to
significant POE association, we recommend that top hits from our
method are followed up in family studies, where parental origin of
alleles can be inferred. In addition, our variance based POE test
for GWAS data is naturally much less powerful than actually
testing the mean values of the two heterozygous subgroups in trios.
However, GWASs of unrelated individuals are several-fold more
numerous and typically much larger than studies with a trio
design, hence our methodology provides a great advance in
parent-of-origin research by providing means to exploit all
available GWAS data of unrelated individuals in order to identify
parent-of-origin effects on continuous phenotypes.

8
>
< yi {mAA
zi ~ yi {mAB
>
:
yi {mBB

Materials and Methods
Ethics statement
All participating studies were approved by the respective
institutional Ethics Committees. All study participants gave written
consent including for genetic studies.

gi ~AA
gi ~AB
gi ~BB

Here gi stands for the genotype of individual i, and mj represents
the median phenotype value in genotype group j, where j can take
the values of AA, AB or BB. We then regress the absolute
deviations from the median onto a 0–1 coded genotype group
identifier (1 for heterozygous and 0 for homozygous individuals) in
order to estimate the POE effect size [31]. This regression result in
a slope estimate

Detecting parent of origin effects
If we denote the alleles of a bi-allelic SNP by ‘‘A’’ (reference)
and ‘‘B’’ (alternative) the possible genotypes are A/A, A/B and B/
B. Standard GWASs estimate the effect of the alternative allele
dosage on the phenotype in question. In this work we are
interested in associations in which a phenotype (y) is influenced by
the alleles of a particular SNP and the effect depends on the
parental origin of these alleles. In the presence of a parent-oforigin effect the heterozygous genotype group is split into two
subgroups, depending on the parental origin of the A and B alleles.
We assume that the phenotype of any individual in the A/A
genotype group is modelled by yAA ~mAA ze, where mAA is the
mean and eis an individual level error with mean zero and
variance s2 . If the maternal and paternal effects of the B allele are
bM andbP , it follows that the phenotype of an individual in the B/
B group is yBB ~(mAA zbM zbP )ze and its variance is s2 . (Note
that as a consequence the maternal and paternal effects of the A
allele are {bP and {bM .) Here we assume s2 is constant across
genotype groups (A/A, A/B and B/B) and bM andbP are fixed
effects. The effects of violations of these assumptions are covered in
the discussion. The phenotype in the heterozygous group is a
50%–50% mixture of two distributions (Fig 1a):

X

where ahet ~

^
b~ahet {ahom ,
0
Dzi D=nAB and ahom ~@

i:gi ~AB

X

Dzi Dz

i:gi ~AA

X

1
Dzi DA

i:gi ~BB

=(nAA znBB ). The corresponding standard error is
SEb 2 ~


RSS nAB (nAA znBB )
,
n{1
n

where
RSS~

X

(zi {a)2 {^
b2 nAB (nAA znBB )=n and a~

i

yAB ~mAA zpbM z(1{p)bP ze,

X

Dzi D=n:

i

Finally, the POE P-value is assigned based on the test statistic
^
b=SEb~N(0,1). The test was extended to imputed genotype
probabilities and implemented in the latest version (v0.98) of the
Quicktest software (http://www3.unil.ch/wpmu/sgg/quicktest/).
The robustness of this test to deviations from normality has been
studied in [32] and its power in [31].

where p is a Bernoulli random variable (with parameter K), taking
values p~1 if the B allele is inherited from the mother and p~0 if
inherited from the father. The heterozygous phenotype distribution can be simplified to yAB ~(mAA zbP )zp(bM {bP )ze Since
p and e are independent random variables, the phenotypic
variance of the heterozygous genotype group s2AB is

SNP selection strategy
We applied our POE test genome-wide to all HapMap imputed
markers in a set of cohorts and results were combined across
cohorts using fixed-effect inverse-variance weighting meta-analysis. SNPs were selected for replication if they met at least one of the
following two criteria: (1) POE P-value ,561026 or (2) POE Pvalue ,561024 and within 500 kb of previously reported
imprinted regions according to the Catalogue of Parent of Origin
Effects database (http://igc.otago.ac.nz/home.html). At loci
which met either criteria, a lead SNP (with the strongest POE
association) was identified; other markers within 1 Mb or in LD
(r2.0.1) were excluded from further investigations. In total
2,673,768 HapMap imputed and genotyped SNPs were analysed,

1
Var(yAB )~Var(p)(bM {bP ) zVar(e)~ (bM {bP )2 zs2
4
2

If a parent-of-origin effect is present bM andbP are different,
thus s2AB is larger than the variance observed in the
homozygous groups (s2 ) (Figure 1). Therefore, although in
regular GWAS data we cannot identify the two subgroups
within A/B genotypes, we can detect POE via increased
phenotypic variance in the heterozygous group relative to the
homozygous groups.
PLOS Genetics | www.plosgenetics.org
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of which 29,457 were considered as lying in imprinted regions,
criterion (2). Using the procedure of Gao et al. [33] we estimated
the effective number of tests considered by each criterion to be
,1,000,000 and 6,100 respectively, justifying the ,100 fold drop
in the P-value threshold applied to the second criterion.

group, compared to the two homozygous groups by an appropriate parameter choice for a. Using a second order Taylor
expansion the variance of the transformed phenotype in the
heterozygous group can be estimated by
Var(g(yDG~AB))&g0 (m)2 s2

Testing in family-based studies

1
z g00 (m)½Var((yDG~AB)2 ){4m2 s2 
4

We tested our findings in family-based studies using a simplified
parental asymmetry test [34] (PAT). For each target SNP, in each
family we searched for trios (or parent-offspring pairs) with
heterozygous offspring and determined the parent of origin of the
alleles (whenever possible, i.e. at least one homozygous parent).
From each family at most one heterozygous offspring with known
parental origin was then collected and grouped according to the
parental origin of the alleles. Note that although POE is acting in
every genotype group, it can only be detected in the heterozygous
group.
As at the discovery phase, we used sex-, age- and age2-corrected
BMI residuals as phenotype. The equality of phenotypic means in
the two groups was tested using a Student t-test. When significant
differences were detected we also estimated the difference between
paternal and maternal effect sizes, which is simply the difference
between the phenotype averages in the paternal- and maternalgroups.

If we assume the phenotype follows a Gaussian distribution
(yDG) then, Var((yDG~AB)2 ) simplifies to 4m2 s2 z2s4 and thus
1
Var(g(yDG~AB))&g0 (m)2 s2 z g00 (m)2 s4
2
Without loss of generality one can assume that s2 ~1. The
variance in AA genotype group can be estimated similarly and
thus
Var(g(yDG~AB)){Var(g(yDG~AA))
1
&½g0 (m)2 {g0 (m{d)2 z ½g00 (m)2 {g00 (m{d)2 
2

Effect size estimation
In order to estimate paternal bP ) and maternal (bM ) effect sizes
it is sufficient to know their mean (bM zbP )=2 and their difference
(bM {bP ). The difference between paternal and maternal effect
alleles can also be derived from GWAS of unrelated individuals. It
is easy to see that the test statistic defined as

Using the special form of g(t), the variance difference can be
expressed as
Var(g(yDG~AB)){Var(g(yDG~AA))




1
e2ad
a2 ead (1{ead )
{
{
&a2
16 (1zead )4
2 (1zead )3


e2ad
ead (1{ead )
2 1
{
{
~a
16 (1zead )4
2(1zead )3


1
{f (a,d)
~a2
16



(nAA {1)s2AA z(nBB {1)s2BB
T~4 s2AB {
nAA znBB {2
gives an unbiased estimate of (bM {bP )2 . Since Var(s2oo )~
2
1
1
s4oo
, the variance of T is &
z
. Therefore,
noo {1
nAB nAA znBB
the absolute difference in paternal and maternal effects (DbM {bP D)
can be estimated if the phenotypic variances in the three genotype
groups are known. However, these estimates will be strongly
subject to the winner’s curse [35], thus we used the family studies
to derive more reliable estimates of (bM {bP ). To reduce the
effect of differences in the distribution of BMI between the familybased studies, we meta-analysed the difference estimates
(bM {bP ) from each study in order to obtain a combined estimate
of (bM {bP ). The average of the maternal- and paternal effects,
(bM zbP )=2, is the association effect size using a simple additive
genetic model, which can be most accurately estimated from the
largest-to-date meta-analytic study on BMI [10] (including
,250,000 individuals).

and since g0 (m{d)~g0 (mzd) and g00 (m{d)~{g00 (mzd)
Var(g(yDG~AB)){Var(g(yDG~BB))
&Var(g(yDG~AB)){Var(g(yDG~AA)):
It is easy to see that for a fixed d
lim f (a,d)~0

a??

Effect of phenotype transformation in case of marginal
association

As a??, f (a,d)?0 faster than a2 ??, thus for any effect size
d we can find a transformation function g such that the variance
inflation of the heterozygous group exceeds any arbitrary
threshold.

If there is an additive marginal genetic effect influencing the
trait certain transformations may inflate the phenotypic variance
of the heterozygous group. Let m be the phenotypic mean in the
heterozygous group and d the marginal effect of the SNP (on the
original scale). Let g(t) denote an S-shaped transformation
1
function of the form
that is applied to the trait.
1zea(t{m)
In the following we show that for any d value arbitrarily large
phenotypic variance inflation can be achieved in the heterozygous
PLOS Genetics | www.plosgenetics.org

Cell lines, nucleic acids isolation, sequencing and qPCR
Lymphoblastoid cell lines were derived from peripheral blood
leukocytes of 95 members of 11 CEPH families [36] (#102, #884,
#1333, #1340, #1341, #1345, #1346, #1347, #1362, #1408,
#13292). They were purchased from the Coriell Cell Repository
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are strongly correlated therefore expected P-values were computed
by estimating the effective number of tests For expected P-values
we computed the effective number of tests [33].
(PNG)

(http://ccr.coriell.org/), and cultured as previously described [37].
DNA was extracted by using the QIAamp DNA Mini kit
(QIAGEN), and RNA by using the RNeasy Mini kit (QIAGEN),
according to the manufacturer’s instructions. Primer sequences
were designed to amplify a 328-bp region on chromosome 8 that
spans the rs2471083 polymorphism (forward primer: 59-ACCACAGAAGTCAGTAGACGAG-39; reverse primer: 59- GTGACATTGGGAGCATGGGA-39) and a 146-bp region on chromosome 20 that spans the rs3092611 polymorphism (forward primer:
59-GCCACCAGTGGTCTGATAGT-39; reverse primer: 59TAACTCGTCATTCTGCCCTGG -39). PCR amplification
was performed in a 25 ml reaction using GoTaq polymerase
(Promega). After purification of PCR products (ExoSAP-IT, USB),
sequencing reactions were carried out by using 1 ml of each of the
3.2 mM sequencing primers and 0.5 ml of BigDye Terminator v1.1
(Applied Biosystems). Following on-column purification (EdgeBio),
sequencing products were run on an ABI-3130 XLS sequencer
(Applied Biosystem). To synthesize cDNA, 2 mg of total RNA was
retrotranscribed using the Superscript III reverse transcriptase
(Invitrogen/Life Technologies) according to the manufacturer’s
instructions and a mix of random hexamers and oligo-dT that
facilitate the detection of poorly expressed genes. To validate
primers for qPCR, we first performed a series of test amplifications
by using a defined range of primer concentrations (50–200 nM).
We then loaded 10 ml of each qPCR product on 1% agarose gels
to check the specificity of the amplification product, which should
correspond to a 113-bp (KCNK9) and 148-bp (SLC2A10)
fragment. To test KCNK9 and SLC2A10 PCR efficiency a
standard curve made of five serial dilutions of brain and lung
cDNA were used, respectively, since the two genes are known to
be highly expressed in these organs. We obtained a standard curve
slope of 23.49 for KCNK9 and of 23.37 for SLC2A10,
corresponding to 94% and 98% PCR efficiency. For more details
see Supplemental Data S1.

Figure S3 Left hand side plots describe methylation associations

with BMI in MZ twins. Each point is a methylation probe,
X-axis represents their physical position and y-axis the 2log10
association P-value with BMI. Location of the target SNP is
indicated by the dashed line. Note that rs3092611 was used as a
proxy for rs3091869 (r2 = 0.998). The corresponding QQ-plots
appear on the right hand side. Neighbouring methylation probes
are strongly correlated therefore expected P-values were computed
by estimating the effective number of tests For expected P-values
we computed the effective number of tests [33].
(PNG)
Figure S4 POE association results for previously reported
imprinted BMI linkage regions. Second dashed line corresponds
to the Benjamini-Hochberg 5% FDR threshold.
(PNG)

POE association P-value QQ-plot for the top 58
independent SNPs with marginal BMI-association P-value ,1025
in Speliotes et al. [10].
(PNG)
Figure S5

Table S1

Table S2 Brief summary of the participating cohorts.

(XLSX)
Table S3 Information on the genotyping methods in the
participating cohorts.
(XLSX)
Table S4 Replication of the 6 discovery SNPs in family studies.
Extended version of Table 2.
(XLSX)

Comparing Ct values
The output of the analysis was threshold cycles (Ct), i.e. the
number of cycles at which the fluorescent signal of the reaction
crosses a pre-determined threshold value. Since standard quantification methods (including normalization by housekeeping genes)
introduce a considerable amount of experimental noise for very
lowly expressed genes, raw Ct values were used to perform an
absolute quantification of KCNK9 and SLC2A10 transcripts. As
negative controls, housekeeping genes (HPRT1, GAPDH) were
also tested for parent-origin-effect to exclude the possibility that
the observed difference in KCNK9 and SLC2A10 expression
levels was due to the sample preparation process. Raw Ct values
were inverse-normal quantile transformed and a linear mixed
model was fitted (using the R function lmer) modelling the
technical replicates as random effects and parental origin as a fixed
effect.

Table S5 Parental asymmetry test results for our 6 candidate
SNPs in adolescent population.
(XLSX)
Table S6 Analysis of the effect of gender- and age-correction
and phenotype transformations on the POE association results.
(XLSX)
Table S7 Genotyping results and parental allele determination

for members of the CEPH families.
(XLSX)
Table S8 Association results between methylation- and BMIdifferences among MZ twins of the TwinsUK study.
(XLSX)
Table S9 POE association P-values for the 32 SNPs associated
with BMI in the largest-to-date meta-analysis [10].
(XLSX)

Supporting Information
Figure S1 QQ-plot of the POE test P-values for SNPs in

imprinted regions (left) and for the whole genome (right).
(PNG)

POE association P-values for the top 58 independent
SNPs with BMI-association P-value ,1025 in the largest-to-date
meta-analysis [10].
(XLSX)
Table S10

Figure S2 Left hand side plots describe SNP-methylation

associations (mQTLs), where each point is a methylation probe.
X-axis represents their physical position and y-axis the 2log10
association P-value with the target SNP, whose location is
indicated by the dashed line. Note that rs3092611 was used as a
proxy for rs3091869 (r2 = 0.998). The corresponding QQ-plots
appear on the right hand side. Neighbouring methylation probes
PLOS Genetics | www.plosgenetics.org

Description of the BMI distribution in the participat-

ing cohorts.
(XLSX)

Data S1 Supporting information contain text on the expressionand methylation analysis, the effective sample size derivation in
mother-offspring vs trio studies, POE look-ups for SNPs with
marginal BMI association, study descriptions and acknowledgements.
(DOCX)
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